The Sleep Disorders Channel is supported through educational grants from Alkermes and Takeda.
VJNeurology is an independent medical education platform. Channel supporters have no influence over the production of content.
SLEEP 2026 | Updates in RLS: recent treatment guidelines and advances in non-pharmacological treatments
Ambra Stefani, MD, PhD, Medical University of Innsbruck, Innsbruck, Austria, comments on the latest updates in the research field of restless legs syndrome (RLS). These include revised treatment guidelines highlighting the risks of augmentation associated with long-term use of dopaminergic agents and new non-pharmacological treatments, such as peroneal nerve stimulation. This interview took place at the 40th annual meeting of the Associated Professional Sleep Societies (APSS) in Baltimore, MD.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
